Soon Your Car Will Know When You Are Having A Heart Attack — And Know How To React

Soon your car will know when you are having a heart attack — and know how to react

Soon your car will know when you are having a heart attack — and know how to react

Car manufacturers constantly upgrade safety technology. In 1958, Saab was the first to make seat belts standard. In the early 1970s the Oldsmobile Toronado could be purchased with high-mounted brake lights and airbags. Now with rapid advances in wearables and autonomous driving systems, a new wave of safety technology is on the way — allowing cars to react to medical emergencies.
Toyota and Ford are each independently researching how to pair health sensors with autonomous driving technology so that vehicles will be able to pull off the road and call for help if they determine a passenger is having either cardiac trouble or a diabetic event.
Chuck Gulash, a senior executive engineer at Toyota and director of its Collaborative Safety Research Center in Ann Arbor, Michigan, said heart rate and blood glucose levels can be effectively monitored, as they are associated with a relatively high number of vehicle crashes.
He referenced a 2009 National Highway Traffic Safety Administration study, which found that diabetic events were behind 20 percent of crashes precipitated by driver-reported medical emergencies, and heart attacks accounted for an additional 11 percent. As people are not always aware they're having medical trouble, the actual figure could be higher.
"We've spent 30 years scientifically measuring crash criteria, but there wasn't a lot of research into physiological metrics," Gulash said.
Heart-related medical issues behind the wheel are extremely dangerous because the sufferer can lose consciousness, said Dr. Nitish Badhwar, professor of clinical medicine and direct Continue reading

Rate this article
Total 1 ratings
The 3 Best Diabetes Stocks to Buy in 2018

The 3 Best Diabetes Stocks to Buy in 2018

Diabetes is a chronic condition that occurs when the body loses its ability to properly metabolize sugar. Without treatment, people with diabetes end up with too much sugar flowing through their bloodstream, which can lead to a wide range of health problems.
More than 30 million Americans already have diabetes, and another 84 million are at risk of developing the disease. Given these massive numbers, perhaps it isn't shocking to learn that diabetes costs the U.S. healthcare system more than $245 billion annually.
A market opportunity that large has attracted the attention of plenty of publicly traded companies:
Market Cap
Abbott Laboraties
$96 billion
Continuous glucose monitor
$84 billion
Becton, Dickinson
$48 billion
Diagnostic and delivery devices
$3.8 billion
Continuous glucose monitor
Eli Lilly
$89 billion
Insulin and pharmaceuticals
$3.3 billion
Insulin pump
Johnson & Johnson (NYSE:JNJ)
$381 billion
Glucose monitor and pharmaceuticals
Lexicon Pharmaceuticals
$1.1 billion
$364 million
Inhaled insulin
$106 billion
Insulin pump and continuous glucose monitor
Novo Nordisk (NYSE:NVO)
$123 billion
Insulin and pharmaceuticals
$120 billion
Insulin and pharmaceuticals
Senseonics Holdings
$360 million
Continous glucose monitor
Data source: Yahoo! Finance. Market cap data as of 10/25/17.
But which of these diabetes stocks is the best bet for investors heading into 2018? Here are my three favorites.
A big competitor throws in the towel
Roughly 3 millio Continue reading

3 Top Diabetes Stocks to Buy Now

3 Top Diabetes Stocks to Buy Now

Diabetes is huge problem for Americans. Between 1990 and 2010, the number of U.S. residents with diabetes tripled, and the number of new cases annually doubled. Both prevalence and costs associated with diabetes are projected to increase by more than 50% by 2030.
But where there's a problem, there's also an opportunity. Healthcare companies continue to develop innovative new approaches to treating and managing diabetes. This innovation in turn creates value for investors.
At least 15 publicly traded companies have current products addressing diabetes either on the market or in development. A few of these stocks hold the potential to generate market-beating returns for investors. I think that Abbott Laboratories (NYSE:ABT), Becton, Dickinson and Company (NYSE:BDX), and Johnson & Johnson (NYSE:JNJ) will especially stand out over the next few years. Here's why these are three top diabetes stocks to buy now.
Abbott Labs
Abbott Labs claims a market cap of close to $98 billion. The company's primary focus in the past has been on branded generic drugs, diagnostic systems and tests, nutritional products, and cardiovascular and neuromodulation medical devices. Abbott's diabetes care unit revenue wasn't even listed separately in the company's financial statements.
However, diabetes should be much more important to Abbott in the future. In September, the U.S. Food and Drug Administration (FDA) approved the company's FreeStyle Libre Flash Glucose Monitoring System. It's the first continuous glucose monitoring (CGM) system approved by the FDA that doesn't require a finger-stick blood sa Continue reading

The most innovative companies in diabetes

The most innovative companies in diabetes

Diabetes affects a startling number of people worldwide -- some 415 million in 2015, with 44.3 million of those in North America. About a third of people with diabetes do not know they have it.
Last year Quid kicked off a new series focusing on Type 2 diabetes (which accounts for nearly 95% of the world’s cases), including an analysis of 40,000 patient posts from a leading diabetes forum.
Still, we wanted to take a closer look at the disease, specifically at innovative companies treating diabetes.
First we looked in our proprietary company database of 50,000 startups to see which are receiving the largest VC investments and for what.
We identified more than 1,300 companies playing in the diabetes landscape. In the network above, 9.6% of companies focus on research and drug discovery, with a whopping $2.9 billion in investment in this area.
And even though it includes fewer companies and makes up a much smaller portion of the network, clinical trial-stage drug manufacturers pulled in the next-highest investment figure, roughly $2 billion in total since 2012. Next, companies in glucose monitoring, diagnostics, and immune-based therapies make up a significant portion of the network and account for a huge chunk of the funds raised.
One cluster was particularly interesting in this map: startups in the biotech, small molecules and drug delivery cluster account for just 2.7% of the network but pulled in relatively high investment dollars, topping $955 million.
Zooming in, we see that companies in this cluster produce very interesting technologies indeed.
Delpor, for example, man Continue reading

Time To Buy Medtronic? Watch Diabetes Segment Transformation

Time To Buy Medtronic? Watch Diabetes Segment Transformation

Medtronic is confident of filling the supply-demand gap in its diabetes franchise by end of FY 2018.
The company plans to launch next generation professional CGM device for type 2 diabetes patients in fiscal year 2018.
Partnerships with clinics and hospitals for diabetes management and prevention are expected to help Medtronic offer integrated care to patients.
The company has also entered intofavorable relationships with major payers in USA.
However, investors should be aware ofcertain business risks of the diabetes segment.
Medtronic (MDT) is one of the few medical device companies with product portfolio vastly diversified across therapeutic areas and geographies. The inversion deal with Ireland based Covidien has not only helped the company to shift to lower-tax base but has also vastly expanded the company’s geographic and therapeutic footprint. And then the recently concluded divestiture deal with Cardinal Health of non-core and low growth assets for a consideration of $6.1 billion has truly landed this company in an enviable spot.
Once Medtronic manages to put to rest the supply constraints it is facing in its diabetes business, I believe that the company can easily reach the 12-month consensus target price for Medtronic, of around $91.11.
The diabetes group currently contributes only about 6.3% to Medtronic’s total revenues. However, it is on a cusp of major transformation, one that is capable of lifting or dragging both investor sentiment as well as share price of this diversified medical device player. It should be noted that the lower-than-anticipated Continue reading

No more pages to load

Popular Articles

  • Your Urine And Diabetes: What You Should Know

    Paula’s story Paula came to see mcomplaining that her urine smelt funny. She had been referred to through a friend who had diabetes, and who thought that I might be able to help Paula understand why her pee smelled funny. “My friend told me my urine smells like diabetes,” said Paula. “She said she had that same fruity smell when she got diagnosed.” Paula said her urine smelled like, “S ...

  • Diabetes Skin Care – What You Need to Know and What You Can Do

    Taking care of our skin is always important, but in diabetes skin care requires more consideration. The skin, our body’s largest organ, is a vital physical barrier between the outside world and everything inside us. Although it seems like a pretty simple thing, there are many blood vessels, nerves and various other structures within it. These all affect the integrity of our skin, and influences ...

  • Cancer, diabetes and heart disease diet: Is THIS the healthiest way to eat your eggs?

    Heart disease, cancer and diabetes risk could be cut by losing weight Risk reduced by avoiding inflammatory foods Eggs are the most nutritious foods you can eat Poached and hard boiled eggs had the fewest calories Heart disease, cancer and diabetes risk could be reduced by maintaining a healthy weight and reducing inflammation - and eating enough eggs in your diet could be the key. Despite being v ...

  • Dairy, Diabetes, and Your Heart

    My wife’s grandfather passed away two weeks ago. At 94, he'd lived an amazing life. He grew up in a family that owned large areas of land near Farmington, New Mexico, and Durango, Colorado. He served as a pilot in World War II, married a wonderful woman, and had seven children. His wife died in her late fifties of ovarian cancer, and he lived another 40 years alone as a widower. He worked hard h ...

  • How Uncontrolled Diabetes Damages Your Heart, Eyes, Kidneys, Nerves, Teeth and More

    Diabetes is a cluster of disorders characterized by high blood sugar levels that persist over a long period. It is one of the most common disorders of our time. According to the International Diabetes Federation, 387 million people worldwide were living with diabetes by the year 2014. In the U.S. alone, 29.1 million people have diabetes, out of which 8.1 million remain undiagnosed, according to th ...

  • Start Infusing Cucumber to Your Daily Water Intake: This Will Burn Fat, Protect the Heart and Prevent Diabetes!

    Numerous celebrities have testified to the effectivity of this method of adding cucumber to their daily water intake and more and more people have been taking advantage of its health benefits. Cucumber water is one of the best natural drinks you can consume to detox your body and get rid of the toxins accumulated in it, due to the high amounts of water and fiber. Additionally, the cucumber water c ...

  • Poor sleep can increase risk of heart disease, Type 2 diabetes, stroke and more here is why a good nights rest is great for your health

    Poor sleep can increase risk of heart disease, Type 2 diabetes, stroke and more here is why a good nights rest is great for your health The better we sleep at night, the more focused and productive we are POOR sleep can can increase risk of heart disease, Type 2 diabetes, stroke and more. Barry Smith, head at Great Yarmouth High School, Norfolk, has told parents to get teen kids in bed by 9pm ...

  • Intermittent Fasting Reduces Your Diabetes and Heart Disease Risk, Studies Say

    Intermittent Fasting Reduces Your Diabetes and Heart Disease Risk, Studies Say Did you know that aside from helping you lose weight and supporting your fitness goals, intermittent fasting can also reduce your risk of chronic diseases, particularly heart disease and diabetes? According to a 2013 review published in the British Journal of Diabetes and Vascular Disease, obese or overweight indivi ...

  • Diabetes, Heart Disease, and You

    Diabetes is a common disease that is on the rise in America. Having diabetes raises your risk for developing other dangerous conditions, especially heart disease and stroke. November is National Diabetes Month, a time to raise awareness about preventing and managing diabetes and protecting yourself from its complications. Diabetes is a serious condition that happens when your body can’t make eno ...

Related Articles